Machka K, Dickert H, Braveny I
Arzneimittelforschung. 1980;30(2):304-7.
The antibacterial activity of ampicillin, ticarcillin, azlocillin, mezlocillin and piperacillin was investigated in 1112 fresh clinical isolates using the microdilution technic. Ampicillin was the most active agent against enterococci and ticarcillin against Staphylococcus aureus, 91% of the latter being inhibited by 32 mg/l. 95% of strains of Pseudomonas aeruginosa were susceptible to piperacillin and 90% to ticarcillin and azlocillin. Piperacillin was still active against half of the azlocillin-resistant strains of Pseudomonas aeruginosa. Against the Enterobacteriaceae, mezlocillin and piperacillin were equally active: 31% of these strains were resistant to both drugs. Amongst the various strains the percentage of resistance was highest in Klebsiella (60%). Analysis of resistance patterns of Enterobacteriaceae showed almost completely parallel resistance between these two drugs the difference being less than 3%. Piperacillin, however, had the broadest spectrum of all the penicillins tested.
采用微量稀释技术,对1112株新鲜临床分离菌进行了氨苄西林、替卡西林、阿洛西林、美洛西林和哌拉西林的抗菌活性研究。氨苄西林对肠球菌活性最强,替卡西林对金黄色葡萄球菌活性最强,91%的金黄色葡萄球菌可被32mg/L的替卡西林抑制。95%的铜绿假单胞菌菌株对哌拉西林敏感,90%对替卡西林和阿洛西林敏感。哌拉西林对半数阿洛西林耐药的铜绿假单胞菌菌株仍有活性。对于肠杆菌科细菌,美洛西林和哌拉西林活性相当:31%的此类菌株对这两种药物均耐药。在各种菌株中,克雷伯菌的耐药率最高(60%)。肠杆菌科细菌耐药模式分析显示,这两种药物之间的耐药情况几乎完全平行,差异小于3%。然而,在所有测试的青霉素中,哌拉西林的抗菌谱最广。